Inflammatory biomarkers as prognostic indicators for liver cirrhosis

Background Severity of liver cirrhosis is commonly assessed by Child–Pugh and model of end-stage liver disease (MELD) scores, which reflect liver dysfunction mainly and do not assess associated systemic events, which influence the failure of other organs. Aim To study the role of serum level of cope...

Full description

Bibliographic Details
Main Authors: Naglaa Abou-Elfattah Tawfik, Naglaa A El-Gendy, Hanaa Abou Elyazid Abou Elhassan, Eman Elshohat Ebrihem, Rayyh Abdelazeem M Saleh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Al-Azhar Assiut Medical Journal
Subjects:
Online Access:http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2019;volume=17;issue=1;spage=68;epage=74;aulast=Tawfik
id doaj-d5b01ac1f524443abfa3da9b8295ae0b
record_format Article
spelling doaj-d5b01ac1f524443abfa3da9b8295ae0b2021-04-20T08:31:11ZengWolters Kluwer Medknow PublicationsAl-Azhar Assiut Medical Journal1687-16932019-01-01171687410.4103/AZMJ.AZMJ_15_19Inflammatory biomarkers as prognostic indicators for liver cirrhosisNaglaa Abou-Elfattah TawfikNaglaa A El-GendyHanaa Abou Elyazid Abou ElhassanEman Elshohat EbrihemRayyh Abdelazeem M SalehBackground Severity of liver cirrhosis is commonly assessed by Child–Pugh and model of end-stage liver disease (MELD) scores, which reflect liver dysfunction mainly and do not assess associated systemic events, which influence the failure of other organs. Aim To study the role of serum level of copeptin (CPP) and high-sensitivity C-reactive protein (hsCRP) as indicators of prognosis in liver cirrhosis and compare these results with usual prognostic scores, raising the importance of proper management of systemic infections in cirrhotic patients to prevent cirrhosis progression. Patients and methods A cross-sectional study was carried out on 80 cirrhotic patients, who were classified into four equal groups: Child A, B, C, and Child C with systemic infections. Serum CPP and hsCRP were measured by enzyme-linked immunosorbent assay technique. Results There was a statistically significant increase in CPP serum levels among cirrhotic patients [9.70 (7.70–14.30)] in comparison with its serum level in healthy participants [5.95 (5.40–6.75)]. There were gradually increases of CPP serum levels through Child–Pugh A, B, and C groups [6.40 (5.42–8.05), 10.15 (7.75–14.20), and 13.05 (8.77–17.27), respectively] in comparison with the control group. There were positive correlations of CPP with MELD score, Child–Pugh, and hsCRP (r=0.60, 0.71, and 0.60, respectively, P<0.000). There was a significantly increase in serum level of hsCRP among cirrhotic patients [9.90 (7.12–16.67)] than control group [2.50 (1.67–5.91)]. Its median values and interquartile range concentrations were the lowest among healthy group and increased gradually through Child–Pugh A, B, and C and Child–Pugh C with infection groups [2.50 (1.67–5.91), 7.15 (6.32–9.45), 8.35 (7.12–12.17), 9.20 (6.95–13.15), and 20.35 (14.85–32.22), respectively] (P=0.000). There were significant positive correlations of hsCRP with CPP, MELD score, and Child–Pugh (r=0.51, 0.54, and 0.75, respectively). Conclusion CPP and hsCRP serum levels can be used as prognostic indicators of liver cirrhosis and account for systemic infections involved in deterioration of liver cirrhosis.http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2019;volume=17;issue=1;spage=68;epage=74;aulast=Tawfikchild–pugh scorecopeptinhigh-sensitivity c-reactive proteinmodel of end-stage liver disease score
collection DOAJ
language English
format Article
sources DOAJ
author Naglaa Abou-Elfattah Tawfik
Naglaa A El-Gendy
Hanaa Abou Elyazid Abou Elhassan
Eman Elshohat Ebrihem
Rayyh Abdelazeem M Saleh
spellingShingle Naglaa Abou-Elfattah Tawfik
Naglaa A El-Gendy
Hanaa Abou Elyazid Abou Elhassan
Eman Elshohat Ebrihem
Rayyh Abdelazeem M Saleh
Inflammatory biomarkers as prognostic indicators for liver cirrhosis
Al-Azhar Assiut Medical Journal
child–pugh score
copeptin
high-sensitivity c-reactive protein
model of end-stage liver disease score
author_facet Naglaa Abou-Elfattah Tawfik
Naglaa A El-Gendy
Hanaa Abou Elyazid Abou Elhassan
Eman Elshohat Ebrihem
Rayyh Abdelazeem M Saleh
author_sort Naglaa Abou-Elfattah Tawfik
title Inflammatory biomarkers as prognostic indicators for liver cirrhosis
title_short Inflammatory biomarkers as prognostic indicators for liver cirrhosis
title_full Inflammatory biomarkers as prognostic indicators for liver cirrhosis
title_fullStr Inflammatory biomarkers as prognostic indicators for liver cirrhosis
title_full_unstemmed Inflammatory biomarkers as prognostic indicators for liver cirrhosis
title_sort inflammatory biomarkers as prognostic indicators for liver cirrhosis
publisher Wolters Kluwer Medknow Publications
series Al-Azhar Assiut Medical Journal
issn 1687-1693
publishDate 2019-01-01
description Background Severity of liver cirrhosis is commonly assessed by Child–Pugh and model of end-stage liver disease (MELD) scores, which reflect liver dysfunction mainly and do not assess associated systemic events, which influence the failure of other organs. Aim To study the role of serum level of copeptin (CPP) and high-sensitivity C-reactive protein (hsCRP) as indicators of prognosis in liver cirrhosis and compare these results with usual prognostic scores, raising the importance of proper management of systemic infections in cirrhotic patients to prevent cirrhosis progression. Patients and methods A cross-sectional study was carried out on 80 cirrhotic patients, who were classified into four equal groups: Child A, B, C, and Child C with systemic infections. Serum CPP and hsCRP were measured by enzyme-linked immunosorbent assay technique. Results There was a statistically significant increase in CPP serum levels among cirrhotic patients [9.70 (7.70–14.30)] in comparison with its serum level in healthy participants [5.95 (5.40–6.75)]. There were gradually increases of CPP serum levels through Child–Pugh A, B, and C groups [6.40 (5.42–8.05), 10.15 (7.75–14.20), and 13.05 (8.77–17.27), respectively] in comparison with the control group. There were positive correlations of CPP with MELD score, Child–Pugh, and hsCRP (r=0.60, 0.71, and 0.60, respectively, P<0.000). There was a significantly increase in serum level of hsCRP among cirrhotic patients [9.90 (7.12–16.67)] than control group [2.50 (1.67–5.91)]. Its median values and interquartile range concentrations were the lowest among healthy group and increased gradually through Child–Pugh A, B, and C and Child–Pugh C with infection groups [2.50 (1.67–5.91), 7.15 (6.32–9.45), 8.35 (7.12–12.17), 9.20 (6.95–13.15), and 20.35 (14.85–32.22), respectively] (P=0.000). There were significant positive correlations of hsCRP with CPP, MELD score, and Child–Pugh (r=0.51, 0.54, and 0.75, respectively). Conclusion CPP and hsCRP serum levels can be used as prognostic indicators of liver cirrhosis and account for systemic infections involved in deterioration of liver cirrhosis.
topic child–pugh score
copeptin
high-sensitivity c-reactive protein
model of end-stage liver disease score
url http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2019;volume=17;issue=1;spage=68;epage=74;aulast=Tawfik
work_keys_str_mv AT naglaaabouelfattahtawfik inflammatorybiomarkersasprognosticindicatorsforlivercirrhosis
AT naglaaaelgendy inflammatorybiomarkersasprognosticindicatorsforlivercirrhosis
AT hanaaabouelyazidabouelhassan inflammatorybiomarkersasprognosticindicatorsforlivercirrhosis
AT emanelshohatebrihem inflammatorybiomarkersasprognosticindicatorsforlivercirrhosis
AT rayyhabdelazeemmsaleh inflammatorybiomarkersasprognosticindicatorsforlivercirrhosis
_version_ 1721518333923164160